Pall Corporation Expands Global Production Capacity

Rhea-AI Summary

Pall Corporation is expanding its global production capacity with a new facility in Spartanburg County, South Carolina, and acquiring Pall-Austar Lifesciences Limited in China. This expansion involves a $114M investment aimed at enhancing manufacturing of single-use technology to meet the increasing demand driven by COVID-19. The company predicts the creation of approximately 1,100 jobs worldwide in 2021. Additionally, existing facilities in the U.S. and Europe will increase production to support biopharmaceutical manufacturing and expedite vaccine delivery.

Positive

• Investment of $114M to enhance manufacturing capacity.
• Creation of approximately 1,100 jobs globally in 2021.
• Increased output and decreased lead time for critical biopharmaceutical solutions.

Negative

• None.

PORT WASHINGTON, N.Y., April 1, 2021 /PRNewswire/ -- Pall Corporation, a global leader in filtration, separation and purification, continues to increase capacity to meet industry demands driven by COVID-19 with a new manufacturing facility in Spartanburg County, South Carolina and the shareholder acquisition of Pall-Austar Lifesciences Limited, a China-based joint-venture. The Spartanburg County, South Carolina facility is part of a $114M investment which also includes production capacity expansion at seven existing Pall manufacturing facilities across the United States and Europe.  

"These expansion activities will significantly increase output and reduce lead time for critical biopharmaceutical manufacturing solutions."

These expansion activities will significantly increase output and reduce lead time for critical biopharmaceutical manufacturing solutions, such as single-use technology. The company anticipates adding roughly 1,100 jobs globally during 2021 as a result of the expansion. 

Joseph Repp, President, Pall Life Sciences, said: "Demand for single-use technology has increased rapidly in recent years. With the global need for mass manufacturing of COVID-19 vaccines, there is now even more pressure on the existing supply chain. This global capacity expansion will ensure critical products are manufactured and delivered to our customers, so people around the world have access to life-saving vaccines and genes therapies."

Pall's new facility, located at 816 Berry Shoals Road in Duncan, South Carolina, will focus primarily on single-use technology, such as the Allegro™single-use platform. The Pall-Austar Lifesciences Limited acquisition also supports single-use technology manufacturing, primarily for biopharmaceutical customers in China.

Pall's manufacturing facilities in Medemblik, Netherlands; Hoegaarden, Belgium; Bad Kreuznach, Germany; Ilfracombe, UK; Newquay, UK; Fajardo, Puerto Rico; and Pensacola, FL, U.S. will expand capacity to produce and distribute the single-use technology, media and breathing filters necessary to support the current global pandemic and future industry needs. 

About Pall Corporation

Pall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The Company's engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide. For more information visit https://www.pall.com.

Or follow us on social media:
LinkedIn     Twitter     Facebook

Corporate Media Contact:
Pall Corporation
Amanda Comeau
Director, Corporate Communications
(508) 330-0811

View original content to download multimedia:http://www.prnewswire.com/news-releases/pall-corporation-expands-global-production-capacity-301260067.html

SOURCE Pall Corporation

FAQ

What is Pall Corporation's latest investment in production capacity?

Pall Corporation is investing $114M to expand global production capacity.

How many jobs will Pall Corporation create in 2021?

Pall Corporation anticipates adding approximately 1,100 jobs globally in 2021.

Where is Pall Corporation opening a new manufacturing facility?

Pall Corporation is opening a new manufacturing facility in Spartanburg County, South Carolina.

What technology will the new facility in South Carolina focus on?

The new facility will primarily focus on single-use technology.

What is the purpose of acquiring Pall-Austar Lifesciences Limited?

The acquisition aims to support single-use technology manufacturing for biopharmaceutical customers in China.